Related Experiment Video
Updated: Dec 15, 2025

Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes hPSC-CMs Using Multi-electrode Arrays MEAs
Published on: May 12, 2017
Contractility of Induced Pluripotent Stem Cell-Cardiomyocytes With an MYH6 Head Domain Variant Associated With
Min-Su Kim1, Brandon Fleres2, Jerrell Lovett2
1Division of Pediatric Cardiothoracic Surgery, Department of Surgery, Medical College of Wisconsin, Herma Heart Institute, Milwaukee, WI, United States.
Insights
Genetic variants in MYH6 cause hypoplastic left heart syndrome (HLHS) by disrupting sarcomere structure and contractility in atrial cardiomyocytes. This study used patient-derived stem cells to reveal the mechanism behind this severe congenital heart defect.
Area of Science:
- Cardiology
- Genetics
- Developmental Biology
Background:
- Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect with unknown etiology.
- Genetic variants in the MYH6 gene have been previously associated with HLHS.
- Patient-derived induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) offer a model to study HLHS pathogenesis.
Purpose of the Study:
- To investigate the functional impact of the MYH6-R443P variant on cardiomyocyte structure and function.
- To elucidate the role of MYH6 variants in the development of HLHS.
- To establish a cellular model for studying HLHS using iPSC-CMs.
Main Methods:
- Generation and analysis of iPSC-CMs from an HLHS-affected family trio.
- Assessment of sarcomere structure, gene expression (MYH7), and cellular contractility.
- CRISPR/Cas9 gene editing to introduce and correct the MYH6-R443P variant.
- Comparison of iPSC-CMs with patient cardiac tissues (atrial and ventricular).
Main Results:
- iPSC-CMs with the MYH6-R443P variant exhibited dysmorphic sarcomeres and impaired contractility (slower contraction, reduced shortening, slower relaxation rates).
- Sarcomere disorganization was observed in atrial, but not ventricular, tissues from HLHS patients with MYH6 variants.
- CRISPR/Cas9 editing confirmed the MYH6-R443P variant's causal role in the observed phenotypes and its rescue upon correction.
- Isoproterenol treatment did not improve iPSC-CM mechanics.
Conclusions:
- The MYH6-R443P variant leads to sarcomere disorganization and impaired atrial cardiomyocyte contractility, contributing to HLHS.
- Patient-derived iPSC-CMs are a valuable tool for understanding HLHS mechanisms.
- Atrial dysfunction due to MYH6 variants may cause hemodynamic changes that impede left ventricular development in HLHS.
Abstract:
Hypoplastic left heart syndrome (HLHS) is a clinically and anatomically severe form of congenital heart disease; however, its etiology remains largely unknown. We previously demonstrated that genetic variants in the MYH6 gene are significantly associated with HLHS. Additionally, induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) from an HLHS-affected family trio (affected parent, unaffected parent, affected proband) carrying an MYH6-R443P head domain variant demonstrated dysmorphic sarcomere structure and increased compensatory MYH7 expression. Analysis of iPSC-CMs derived from the HLHS trio revealed that only beta myosin heavy chain expression was observed in CMs carrying the MYH6-R443P variant after differentiation day 15 (D15). Functional assessments performed between D20-D23 revealed that MYH6-R443P variant CMs contracted more slowly (40 ± 2 vs. 47 ± 2 contractions/min, P < 0.05), shortened less (5.6 ± 0.5 vs. 8.1 ± 0.7% of cell length, P < 0.05), and exhibited slower shortening rates (19.9 ± 1.7 vs. 28.1 ± 2.5 μm/s, P < 0.05) and relaxation rates (11.0 ± 0.9 vs. 19.7 ± 2.0 μm/s, P < 0.05). Treatment with isoproterenol had no effect on iPSC-CM mechanics. Using CRISPR/Cas9 gene editing technology, introduction of the R443P variant into the unaffected parent's iPSCs recapitulated the phenotype of the proband's iPSC-CMs, and conversely, correction of the R443P variant in the proband's iPSCs rescued the cardiomyogenic differentiation, sarcomere organization, slower contraction (P < 0.05) and decreased velocity phenotypes (P < 0.0001). This is the first report to identify that cardiac tissues from HLHS patients with MYH6 variants can exhibit sarcomere disorganization in atrial but not ventricular tissues. This new discovery was not unexpected, since MYH6 is expressed predominantly in the postnatal atria in humans. These findings demonstrate the feasibility of employing patient-derived iPSC-CMs, in combination with patient cardiac tissues, to gain mechanistic insight into how genetic variants can lead to HLHS. Results from this study suggest that decreased contractility of CMs due to sarcomere disorganization in the atria may effect hemodynamic changes preventing development of a normal left ventricle.
More Related Videos
08:37Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
Published on: March 3, 2021
10:46Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
Published on: November 3, 2011